Moderna, Inc. (MRNA)

R1 RCM Revenue

Moderna had revenue of $142.00M in the quarter ending June 30, 2025, a decrease of -41.08%. This brings the company's revenue in the last twelve months to $3.08B, down -39.05% year-over-year. In the year 2024, Moderna had annual revenue of $3.24B, down -52.75%.

• Revenue (ttm): $3.08B
• Revenue Growth: -39.05%
• P/S Ratio: 3.46
• Revenue / Employee: $530,690
• Employees: 5,800
• Market Cap: 10.68B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.24B	-3.61B	-52.75%
Dec 31, 2023	6.85B	-12.42B	-64.45%
Dec 31, 2022	19.26B	792.00M	4.29%
Dec 31, 2021	18.47B	17.67B	2,200.25%
Dec 31, 2020	803.00M	743.00M	1,238.33%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.